Tagged with M

Indonesia Milan Paleja, country president and general manager of Novartis Indonesia, discusses his main priorities since assuming his current position and the organization’s business expansion strategy, based on enhancing patient access to innovative medicines in both the public and private sectors. Mr. Paleja, you were appointed as country president and general…

Hong Kong Hybribio is a very interesting company, being founded in Hong Kong and now headquartered in Guangzhou as one of the leading providers of in-vitro diagnostic (IVD) assays in Greater China with significant international presence as well. Can you tell us more about the company’s positioning today? “We have launched several…

Hong Kong William Lai YF, CEO of Fortune Pharmacal, discusses the Hong Kong OTC market, the company’s internationalization strategy, and its expanding manufacturing footprint. Could you please introduce us to Fortune Pharmacal? What sets you apart from other OTC companies? “We follow the highest standards by always exploring what the ‘big boys’…

Ukraine Anatoliy Novyk, founder and president of SMC Ecopharm, the only Ukrainian pharmaceutical company to be exclusively focused on its own original drug development, provides insights into Ecopharm’s promising expansion strategy, which should be significantly propelled by the company’s upcoming GMP-certified manufacturing plant. He also provides an in-depth look into their…

Indonesia Aylie Widjaja, managing director at Exeltis Indonesia, shares her excitement about developing the company’s footprint in Indonesia, making it a manufacturing hub for Asia, and highlights the challenges in navigating the public market. How do you see the Indonesian healthcare landscape evolving? “We have to give better options to patients…

Pharma PharmaBoardroom’s readers were polled on what they felt was the most disruptive force in the pharmaceutical industry today. Possible answers were big data and digitalization, patient-centricity, economic austerity, and advancements in supply chain management. Big Data and Digitalization Overall, most respondents chose big data and digitalization (34 percent) and economic…

Algeria In June 2017, PharmaBoardroom hosted an exclusive round table discussion with key players in Algerian healthcare on the role of health economics and patient data in health policy decision making. The participants were Dr Djaouad Brahim Bourkaib, Director General of Social Security in the Ministry of Labor, Jean-Paul Digy, Vice President for…

Austria Dr. Andreas Windischbauer, president of the Austrian Association of Full-Line Pharmaceutical Wholesalers (PHAGO) discusses the organization’s role within the Austrian pharma industry, its current challenges, price pressures, competition, and future prospects. Can you give us a brief overview of PHAGO? “We live in a changing world with a lot of…

USA In 2016, rumours of a weakening FDA followed a disappointing 16 new drugs approved for the full year. However, since the beginning of 2017 the FDA has approved 26 drugs; double the amount of the mid-year average since 2007. “The eight oncology treatments approved by the FDA this year represent…

Japan Kenichi Tamiya, director for Biomedical Policy at the Kobe City Government and managing director of the Kobe Foundation for Biomedical Research and Innovation (FBRI), discusses the central Japanese city of Kobe’s significant potential as a cutting-edge R&D hub for both the national and global life science industries. “Alongside promoting translational…

Ukraine Filya Zhebrovska, chairman of the supervisory board of Farmak and the company’s general director between 1995 and 2017, provides insights into the strategy she has followed to establish Farmak as Ukraine’s largest domestic company and the market leader in the country since 2010. She also documents the impact of the…

Ukraine Taras Velgosh, Adamed’s country manager in Ukraine, provides insights into the great results accomplished by the Ukrainian affiliate of this leading Polish pharmaceutical company despite the deep crisis that has recently affected the Ukrainian market. He also documents the innovative, service-oriented added value that he strives to bring into the…